Hematology-Oncology386

Pub YearTitleAuthor(s)
2019A Machine-Learning Approach Using PET-Based Radiomics to Predict the Histological Subtypes of Lung Cancer고영화, 안미선, 이수진
2020A membrane-tethering pepducin derived from formyl peptide receptor 3 shows strong therapeutic effects against sepsis박준성
2016A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806)강석윤, 최진혁
1996A multicentre comparison of once-daily subcutaneous dalteparin (low molecular weight heparin) and continuous intravenous heparin in the treatment of deep vein thrombosis.김효철
2020A Neuropilin-1 Antagonist Exerts Antitumor Immunity by Inhibiting the Suppressive Function of Intratumoral Regulatory T Cells김철호, 이현우, 정근옥, 함석진
2023A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea최윤석
2011A novel algorithm for detection of adverse drug reaction signals using a hospital electronic medical record database감혜진, 강석윤, 박래웅, 박인휘, 이기영
2014A novel delivery platform for therapeutic peptides.박준성
2023A phase II study on the efficacy of regorafenib in treating patients with c-KIT-mutated metastatic malignant melanoma that progressed after previous treatment (KCSG-UN-14-13)안미선
2024A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH Trial이현우
2016A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis정성현
2015A prospective, multicenter, observational study of long-term decitabine treatment in patients with myelodysplastic syndrome.정성현
2017A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma박준성, 정성현
2021A randomised phase 2b study comparing the efficacy and safety of belotecan vs. topotecan as monotherapy for sensitive-relapsed small-cell lung cancer최진혁
2019A randomized phase II study of palbociclib plus exemestane with GNRH agonist versus capecitabine in premenopausal women with hormone receptor-positive metastatic breast cancer (KCSG-BR 15-10, NCT02592746)강석윤
2013A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancer.강석윤
2017A randomized, multi-center, open-label, phase III study of once-per-cycle DA-3031, a pegylated G-CSF, in comparison with daily filgrastim in patients receiving TAC chemotherapy for breast cancer강석윤
2015A rare case of chronic myelogenous leukemia and plasma cell myeloma in the same patient.박준성, 조성란, 한재호
2011(A)case of primary central nervous system lymphoma : an unusual presentation with hormonal abnormalities and good prognosis after chemo-radiotherapy안소연, 이현우, 정윤석
2019Abrogation of B-Raf(V600E) induced senescence by FoxM1 expression강석윤, 김장희, 박태준, 최용원
1 2 3 4 5 6 7 8 9 10 11 19

Browse